AU Patent

AU2014285058A1 — Reducing adverse side effects of a compound by a neurotoxin

Assigned to Toxcure LLC · Expires 2016-02-18 · 10y expired

What this patent protects

The present invention relates to methods and compositions for treating various side effects associated with the administration of one or more therapeutic compounds. In particular embodiments, the present invention relates to methods of reducing one or more adverse side effects as…

USPTO Abstract

The present invention relates to methods and compositions for treating various side effects associated with the administration of one or more therapeutic compounds. In particular embodiments, the present invention relates to methods of reducing one or more adverse side effects associated with one or more therapeutic compounds by administering a neurotoxin, such as botulinum toxin, in combination with the one or more therapeutic compounds.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014285058A1
Jurisdiction
AU
Classification
Expires
2016-02-18
Drug substance claim
No
Drug product claim
No
Assignee
Toxcure LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.